188 related articles for article (PubMed ID: 22157173)
1. Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
Maherault AC; Nordmann P; Therby A; Pangon B
Clin Infect Dis; 2012 Feb; 54(4):577-8. PubMed ID: 22157173
[No Abstract] [Full Text] [Related]
2. Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Lee NY; Huang WH; Tsui KC; Hsueh PR; Ko WC
Diagn Microbiol Infect Dis; 2011 May; 70(1):150-3. PubMed ID: 21398070
[TBL] [Abstract][Full Text] [Related]
3. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia.
Song W; Moland ES; Hanson ND; Lewis JS; Jorgensen JH; Thomson KS
J Clin Microbiol; 2005 Sep; 43(9):4891-4. PubMed ID: 16145169
[TBL] [Abstract][Full Text] [Related]
4. Emergence of OXA-48-producing Enterobacteriaceae in Switzerland.
Potron A; Schrenzel J; Poirel L; Renzi G; Cherkaoui A; Nordmann P
Int J Antimicrob Agents; 2012 Dec; 40(6):563-4. PubMed ID: 23040008
[No Abstract] [Full Text] [Related]
5. VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases.
Daikos GL; Karabinis A; Paramythiotou E; Syriopoulou VP; Kosmidis C; Avlami A; Gargalianos P; Tzanetou K; Petropoulou D; Malamou-Lada H
Int J Antimicrob Agents; 2007 Apr; 29(4):471-3. PubMed ID: 17229554
[No Abstract] [Full Text] [Related]
6. Intercontinental transfer of OXA-181-producing Klebsiella pneumoniae into New Zealand.
Williamson DA; Heffernan H; Sidjabat H; Roberts SA; Paterson DL; Smith M; Freeman JT
J Antimicrob Chemother; 2011 Dec; 66(12):2888-90. PubMed ID: 21933789
[No Abstract] [Full Text] [Related]
7. Nosocomial liver abscess caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Lin JC; Siu LK; Fung CP; Yeh KM; Chang FY
J Clin Microbiol; 2007 Jan; 45(1):266-9. PubMed ID: 17093025
[TBL] [Abstract][Full Text] [Related]
8. Combination treatment with extended-infusion ceftazidime/avibactam for a KPC-3-producing Klebsiella pneumoniae bacteraemia in a kidney and pancreas transplant patient.
Jacobs DM; DiTursi S; Ruh C; Sharma R; Claus J; Banjade R; Rao GG
Int J Antimicrob Agents; 2016 Aug; 48(2):225-7. PubMed ID: 27396948
[No Abstract] [Full Text] [Related]
9. Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
Chung KP; Tseng SP; Huang YT; Tsai TH; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2011 May; 66(5):1182-4. PubMed ID: 21393195
[No Abstract] [Full Text] [Related]
10. Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India.
Kumarasamy K; Kalyanasundaram A
J Antimicrob Chemother; 2012 Jan; 67(1):243-4. PubMed ID: 21990048
[No Abstract] [Full Text] [Related]
11. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
Nadkarni AS; Schliep T; Khan L; Zeana CB
Am J Infect Control; 2009 Mar; 37(2):121-6. PubMed ID: 19249638
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae isolate in Denmark.
Hasman H; Fjeldsøe-Nielsen H; Lausten T; Berthelsen BG
Int J Antimicrob Agents; 2010 Nov; 36(5):468-9. PubMed ID: 20724117
[No Abstract] [Full Text] [Related]
13. Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala.
Pasteran F; Albornoz E; Faccone D; Gomez S; Valenzuela C; Morales M; Estrada P; Valenzuela L; Matheu J; Guerriero L; Arbizú E; Calderón Y; Ramon-Pardo P; Corso A
J Antimicrob Chemother; 2012 Jul; 67(7):1795-7. PubMed ID: 22461309
[No Abstract] [Full Text] [Related]
14. Emergence of KPC-producing Klebsiella pneumoniae in Texas.
Hirsch EB; Chang KT; Lasco TM; Caeiro JP; Tam VH
Diagn Microbiol Infect Dis; 2011 Feb; 69(2):234-5. PubMed ID: 21251574
[No Abstract] [Full Text] [Related]
15. Use of meropenem by continuous infusion to treat a patient with a Bla(kpc-2)-positive Klebsiella pneumoniae blood stream infection.
Ho VP; Jenkins SG; Afaneh CI; Turbendian HK; Nicolau DP; Barie PS
Surg Infect (Larchmt); 2011 Aug; 12(4):325-7. PubMed ID: 21859337
[TBL] [Abstract][Full Text] [Related]
16. Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin.
Endimiani A; Luzzaro F; Perilli M; Lombardi G; Colì A; Tamborini A; Amicosante G; Toniolo A
Clin Infect Dis; 2004 Jan; 38(2):243-51. PubMed ID: 14699457
[TBL] [Abstract][Full Text] [Related]
17. Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
Roy S; Viswanathan R; Singh AK; Das P; Basu S
J Antimicrob Chemother; 2011 Jun; 66(6):1411-3. PubMed ID: 21393155
[No Abstract] [Full Text] [Related]
18. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium.
Bogaerts P; Montesinos I; Rodriguez-Villalobos H; Blairon L; Deplano A; Glupczynski Y
J Antimicrob Chemother; 2010 Feb; 65(2):361-2. PubMed ID: 20008447
[No Abstract] [Full Text] [Related]
19. Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae.
Gomez S; Pasteran F; Faccone D; Bettiol M; Veliz O; De Belder D; Rapoport M; Gatti B; Petroni A; Corso A
Clin Microbiol Infect; 2013 May; 19(5):E233-5. PubMed ID: 23402333
[TBL] [Abstract][Full Text] [Related]
20. Emergence of nosocomial New Delhi metallo-β-lactamase-1 (NDM-1)-producing Klebsiella pneumoniae in patients admitted to a tertiary care hospital in Kuwait.
Jamal W; Rotimi VO; Albert MJ; Khodakhast F; Udo EE; Poirel L
Int J Antimicrob Agents; 2012 Feb; 39(2):183-4. PubMed ID: 22113192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
